Current Concept and Epidemiology of Systemic Vasculitides
Although a new classification algorithm for systemic vasculitides was proposed by Watts et al. and the Chapel Hill Consensus Conference (CHCC) was updated in 2012, there are currently no validated diagnostic criteria for systemic vasculitides. The Diagnostic and Classification Criteria for Vasculiti...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2014-01-01
|
| Series: | Allergology International |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S1323893015300630 |
| _version_ | 1819075962450477056 |
|---|---|
| author | Takayuki Katsuyama Ken-Ei Sada Hirofumi Makino |
| author_facet | Takayuki Katsuyama Ken-Ei Sada Hirofumi Makino |
| author_sort | Takayuki Katsuyama |
| collection | DOAJ |
| description | Although a new classification algorithm for systemic vasculitides was proposed by Watts et al. and the Chapel Hill Consensus Conference (CHCC) was updated in 2012, there are currently no validated diagnostic criteria for systemic vasculitides. The Diagnostic and Classification Criteria for Vasculitis study (DCVAS) is a global study to develop and improve the diagnostic criteria for systemic vasculitides. The epidemiology of systemic vasculitides differs widely among countries. For example, in the case of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, patients with microscopic polyangiitis (MPA) and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with granulomatosis with polyangiitis (GPA) and with positivity for PR3-ANCA are predominant in northern Europe and the United States. Interstitial lung disease (ILD) occurs more frequently in Asian patients compared with patients in Europe. The incidence and the prevalence of large-vessel vasculitis also differ significantly. Giant cell arteritis (GCA) occurs frequently in northern Europe, unlike Takayasu arteritis (TAK). The ethnic and regional differences in the incidence, prevalence and clinical characteristics of patients with vasculitis should be recognized when we diagnose and treat patients with vasculitis using criteria, and should also be considered when interpreting the results from clinical studies. |
| first_indexed | 2024-12-21T18:33:44Z |
| format | Article |
| id | doaj.art-69ac05b09bc047538c50eee32f6dd829 |
| institution | Directory Open Access Journal |
| issn | 1323-8930 |
| language | English |
| last_indexed | 2024-12-21T18:33:44Z |
| publishDate | 2014-01-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Allergology International |
| spelling | doaj.art-69ac05b09bc047538c50eee32f6dd8292022-12-21T18:54:13ZengElsevierAllergology International1323-89302014-01-0163450551310.2332/allergolint.14-RAI-0778Current Concept and Epidemiology of Systemic VasculitidesTakayuki Katsuyama0Ken-Ei Sada1Hirofumi Makino2Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama, Japan.Although a new classification algorithm for systemic vasculitides was proposed by Watts et al. and the Chapel Hill Consensus Conference (CHCC) was updated in 2012, there are currently no validated diagnostic criteria for systemic vasculitides. The Diagnostic and Classification Criteria for Vasculitis study (DCVAS) is a global study to develop and improve the diagnostic criteria for systemic vasculitides. The epidemiology of systemic vasculitides differs widely among countries. For example, in the case of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, patients with microscopic polyangiitis (MPA) and with positivity for MPO-ANCA are predominant in Asian countries, whereas patients with granulomatosis with polyangiitis (GPA) and with positivity for PR3-ANCA are predominant in northern Europe and the United States. Interstitial lung disease (ILD) occurs more frequently in Asian patients compared with patients in Europe. The incidence and the prevalence of large-vessel vasculitis also differ significantly. Giant cell arteritis (GCA) occurs frequently in northern Europe, unlike Takayasu arteritis (TAK). The ethnic and regional differences in the incidence, prevalence and clinical characteristics of patients with vasculitis should be recognized when we diagnose and treat patients with vasculitis using criteria, and should also be considered when interpreting the results from clinical studies.http://www.sciencedirect.com/science/article/pii/S1323893015300630antineutrophil cytoplasmic antibody-associated vasculitisChapel Hill Consensus Conference nomenclature of systemic vasculitidesepidemiologylarge vessel vasculitispolyarteritis nodosa |
| spellingShingle | Takayuki Katsuyama Ken-Ei Sada Hirofumi Makino Current Concept and Epidemiology of Systemic Vasculitides Allergology International antineutrophil cytoplasmic antibody-associated vasculitis Chapel Hill Consensus Conference nomenclature of systemic vasculitides epidemiology large vessel vasculitis polyarteritis nodosa |
| title | Current Concept and Epidemiology of Systemic Vasculitides |
| title_full | Current Concept and Epidemiology of Systemic Vasculitides |
| title_fullStr | Current Concept and Epidemiology of Systemic Vasculitides |
| title_full_unstemmed | Current Concept and Epidemiology of Systemic Vasculitides |
| title_short | Current Concept and Epidemiology of Systemic Vasculitides |
| title_sort | current concept and epidemiology of systemic vasculitides |
| topic | antineutrophil cytoplasmic antibody-associated vasculitis Chapel Hill Consensus Conference nomenclature of systemic vasculitides epidemiology large vessel vasculitis polyarteritis nodosa |
| url | http://www.sciencedirect.com/science/article/pii/S1323893015300630 |
| work_keys_str_mv | AT takayukikatsuyama currentconceptandepidemiologyofsystemicvasculitides AT keneisada currentconceptandepidemiologyofsystemicvasculitides AT hirofumimakino currentconceptandepidemiologyofsystemicvasculitides |